Contraceptive vaginal ring(NuvaRing) is a new combined hormonal contraceptive method.Each ring contains 2.7mg ethinyl estradiol(EE) and 11.7mg etonogestrel.The ring is characteristic with its ease of use.lower EE syst...Contraceptive vaginal ring(NuvaRing) is a new combined hormonal contraceptive method.Each ring contains 2.7mg ethinyl estradiol(EE) and 11.7mg etonogestrel.The ring is characteristic with its ease of use.lower EE systemic exposure and excellent cycle control.Studies have demonstrated that the efficacy and safety of the ring are equivalent to combined oral contraceptive(COC).The side effects of the ring are fewer and the biocompatibility is good.Recent studies have proved that the NuvaRing is a new,effective hormonal contraceptive option for women.展开更多
Dear Editor,We read with interest your recent article on the impact of combined oral contraceptives on ocular tissues.We report a case of a branch retinal vein occlusion（BRVO）associated with use of an etonogestrel/e...Dear Editor,We read with interest your recent article on the impact of combined oral contraceptives on ocular tissues.We report a case of a branch retinal vein occlusion（BRVO）associated with use of an etonogestrel/ethinyl estradiol vaginal ring（NuvaR ing）,an implantable combined hormonal contraceptive,in a young healthy female with no other identifiable risk factors.展开更多
文摘Contraceptive vaginal ring(NuvaRing) is a new combined hormonal contraceptive method.Each ring contains 2.7mg ethinyl estradiol(EE) and 11.7mg etonogestrel.The ring is characteristic with its ease of use.lower EE systemic exposure and excellent cycle control.Studies have demonstrated that the efficacy and safety of the ring are equivalent to combined oral contraceptive(COC).The side effects of the ring are fewer and the biocompatibility is good.Recent studies have proved that the NuvaRing is a new,effective hormonal contraceptive option for women.
文摘Dear Editor,We read with interest your recent article on the impact of combined oral contraceptives on ocular tissues.We report a case of a branch retinal vein occlusion（BRVO）associated with use of an etonogestrel/ethinyl estradiol vaginal ring（NuvaR ing）,an implantable combined hormonal contraceptive,in a young healthy female with no other identifiable risk factors.
